# Antibiotic medicines: Bill of materials

Source page: https://www.materialinsights.org/products/p_antibiotic_medicines/prod-bom/

#### About these figures

Which unit, study and year the composition figures describe, and how they vary

No source opened gives the make-up of a course in grams or lists its other ingredients. The active ingredient is a penicillin or another antibiotic, made upstream through intermediates such as 6-APA and 7-ACA ^[2]^[16]. Tablets ^[19], capsules ^[24] and powder oral suspensions ^[15] are sold. The primary pack and the excipients are not yet product nodes. Stages are named only: no strains, methods, conditions or recipes are given.

as of 2026-11-14

#### Direct materials

The commodities and chemicals in one unit as bought, with amount, mass share, cost share and recycled content

| Material | Role | Amount in one unit | Share of the unit's mass |
|---|---|---|---|
| [API Small-molecule APIs](https://www.materialinsights.org/chemicals/apis/) | Functional | Not given | – |
| The active ingredient is an antibiotic compound; WHO's guidance covers the steps from making it to formulating finished products, including primary packaging ^[1]. No source opened gives the mass per course. |  |  |  |

as of 2026-11-14

#### How it is put together

The main steps from parts and materials to the finished unit

| Step | What happens | Source |
|---|---|---|
| Intermediate | Building blocks such as 6-APA and 7-ACA are made; the steps are not described here | ^[2]^[16] |
| Active ingredient | The active pharmaceutical ingredient is made; the steps are not described here | ^[1] |
| Formulation | The ingredient is formulated into finished products such as tablets, capsules and powder oral suspensions | ^[1]^[19]^[24]^[15] |
| Primary packaging | The finished product goes into its primary pack before sale | ^[1] |

as of 2026-11-14

#### Sources

1. [New global guidance aims to curb antibiotic pollution from manufacturing](https://www.who.int/news/item//03-09-2024-new-global-guidance-aims-to-curb-antibiotic-pollution-from-manufacturing) World Health Organization, 2024, news release of 3 September 2024
2. [Foreign control of antibiotic supply: American and European import reliance and systemic vulnerabilities (Report No. 2026/06)](https://www.geostrategy.org.uk/research/foreign-control-of-antibiotic-supply/) Council on Geostrategy with the Coalition for a Prosperous America, 2026, think-tank report by Andrew Rechenberg (economist, Coalition for a Prosperous America, an advocacy group) and Patrick Triglavcanin (Council on Geostrategy); ISBN 978-1-917893-22-0; no publication month, no method section and no footnotes for the figures
3. [Sandoz opens antibiotic production facility in Austria](https://chemanager-online.com/en/news/sandoz-opens-antibiotic-production-facility-in-austria) CHEManager International, 2024, 26 March 2024; company claims reported by a trade publication
4. [Aurobindo Pharma, KAPL get approval for promotion of manufacturing bulk drugs](https://medicaldialogues.in/news/industry/pharma/aurobindo-pharma-kapl-get-approval-for-promotion-of-manufacturing-bulk-drugs-73830) Medical Dialogues, 2021, 24 January 2021, by Ruchika Sharma, citing PTI and a Ministry of Chemicals and Fertilizers statement
5. [NPPA Hikes Prices of Key Antibiotics Azithromycin, Amoxicillin Clavulanic Acid](https://medicaldialogues.in/news/industry/pharma/nppa-hikes-prices-of-key-antibiotics-azithromycin-amoxicillin-clavulanic-acid-143145) Medical Dialogues, 2025, 12 February 2025, by Farhat Nasim; reports the review order dated 4 October 2024
6. [The environmental impact of antibiotics](https://ipu.ie/the-environmental-impact-of-antibiotics) Irish Pharmacy Union (IPU Review; Ellen Martin, HSE AMRIC team), 2025, May 2025; review article citing Taylor et al. (2024)

## Other sections

- [Summary](https://www.materialinsights.org/products/p_antibiotic_medicines/index.md)
- [Working](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-working/index.md)
- [Use case](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-evolution/index.md)
- [Interventions](https://www.materialinsights.org/products/p_antibiotic_medicines/prod-interventions/index.md)
